Lithium-Induced Cutaneous Side Effects in Bipolar Disorder Treatment
January 2022
in “
Indian Journal of Psychiatry/Indian journal of psychiatry
”
Studysummary This case report describes a patient who developed a maculopapular rash after starting lithium treatment, highlighting the importance of monitoring skin reactions due to potential impact on treatment adherence.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
A 28-year-old female with first episode mania was treated with sodium valproate, olanzapine, and later lithium. Four days after starting lithium, she developed a maculopapular rash on her forearms, neck, and ventral aspect, which resolved within 5 days after discontinuing lithium. This case highlights the importance of monitoring for cutaneous side effects during lithium treatment to ensure patient adherence.
